BrewDog bars report double-digit growth during World Cup

1 min read     Updated on 22 Jun 2026, 08:52 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

BrewDog, owned by Tilray Brands, achieved double-digit sales growth across its UK bars during the FIFA World Cup, driven by record attendance and strong demand for American craft beer. Brands like SweetWater, Montauk, and Blue Point sold out initial stock within a week, leading to immediate reorders. BrewDog expects the trend to persist as fans seek premier viewing destinations.

powered bylight_fuzz_icon
43687359

*this image is generated using AI for illustrative purposes only.

BrewDog, owned by Tilray Brands, reported record fan turnout and double-digit sales growth across its UK bar network during the FIFA World Cup, as supporters turned venues into high-energy destinations. The growth was fueled by packed venues, strong food and beverage sales, and rising demand for premium craft beer experiences that combine live sport, hospitality, and community.

The tournament accelerated demand for Tilray’s American craft beer portfolio across BrewDog’s UK business. Within the first week, consumer favourites including SweetWater Brewing Company, Montauk Brewing Company, and Blue Point Brewing Company sold through their initial inventory allocations in both bars and e-commerce channels, prompting immediate reorders. BrewDog’s own portfolio, led by Punk IPA, remained among the top-selling beers throughout the period.

Key Performance Highlights

Metric Detail
Sales Growth Double-digit growth on tournament match days
Inventory Status Initial allocations for SweetWater, Montauk, and Blue Point sold out within days
Top-Selling Brand Punk IPA (BrewDog flagship)
Consumer Trend Rising demand for American craft beer styles in the UK

Lauren Carrol, Chief Commercial Officer at BrewDog, attributed the success to the convergence of live sports and the strength of the craft beer category. She noted that the demand for American craft beer extends beyond match days, with consumers discovering brands both online and in bars. Carrol added that the tournament reinforced the role of bars as community gathering places where fans create memories and celebrate together.

BrewDog Waterloo, the UK’s largest bar, saw thousands of supporters gather for tournament action, with fans arriving early and staying longer. The venues offered expansive indoor viewing areas, air conditioning, and wall-to-wall match coverage, providing a comfortable environment for fans to beat the heat. As the tournament continues, BrewDog expects sustained momentum across its bar network.

Will BrewDog adjust its inventory strategy for future major sporting events to prevent stockouts of popular American craft brands?

How does the company plan to convert the influx of one-time World Cup visitors into long-term regular customers?

Can the sustained sales momentum be maintained once the high-energy atmosphere of the tournament concludes?

like15
dislike

Tilray launches ARX, its first premium medical cannabis brand developed and cultivated in Germany

1 min read     Updated on 10 Jun 2026, 04:19 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Tilray Medical Germany introduced ARX, its first premium medical cannabis brand developed and cultivated in Germany at the Aphria RX facility. The brand combines Broken Coast genetics with German precision, produced under EU-GMP standards, and is distributed via CC Pharma and 14U Pharma.

powered bylight_fuzz_icon
42633708

*this image is generated using AI for illustrative purposes only.

Tilray Medical Germany has launched ARX, its first premium medical cannabis brand developed and cultivated in Germany. The introduction of ARX marks a significant step forward in the quality of medical cannabis available in the country and reflects more than two years of development at the Aphria RX facility in Neumünster. Built through disciplined cultivation practices and deep operational expertise, ARX is grounded in the belief that patients and healthcare professionals require consistent, high-quality products.

ARX combines genetics sourced from the Broken Coast renowned library with cultivation expertise developed through years of premium cannabis production in Canada and executed with German precision. Produced and manufactured at Tilray Medical's Aphria RX facility, the brand is supported by the company's established German infrastructure, including national distribution through CC Pharma and 14U Pharma.

Production Standards and Quality Assurance

ARX is produced under strict EU-GMP standards at the Aphria RX facility in Neumünster. Drawing on Broken Coast's cultivation expertise, the production process is designed to support consistency and product integrity. Individual, climate-controlled grow rooms allow each cultivar to be developed under tailored conditions, while continuous monitoring and real-time adjustments help maintain quality throughout cultivation. Fully integrated, in-house operations reduce handling and delays, helping support product consistency without the need for irradiation.

Strategic Importance and Market Position

Rajnish Ohri, President, International, Tilray Brands, stated: "The launch of ARX marks an important milestone for Tilray in Germany as our first premium medical cannabis brand developed and cultivated in-market. Germany continues to lead the evolution of medical cannabis in Europe, and we are committed to supporting that growth with locally produced, high-quality products that meet the needs of patients and healthcare professionals. With ARX, we are strengthening our position in this critical market while advancing consistency, supply reliability, and long-term patient access."

Brand Portfolio and Availability

Since 2014, Broken Coast has been recognized as one of Canada's original Licensed Producers of medical cannabis and remains a leading producer of premium cannabis products, with deep expertise in strain selection and phenotyping. ARX is now part of Tilray Medical's global portfolio of medical cannabis brands, which includes Tilray Medical, Good Supply, Redecan, and Broken Coast.

How will the launch of ARX impact Tilray's market share in Germany's medical cannabis sector?

What are the potential expansion plans for ARX into other European markets?

How might local production under EU-GMP standards influence regulatory policies for medical cannabis in Germany?

like20
dislike
Must Read Next

Earnings

Corporate Actions

Stocks